Smithfield Trust’s Usana Health Sciences USNA Stock Holding History

Smithfield Trust’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-160	Closed	-$12K	–	1101
2017 Q4	$12K	Hold	160	–	–	﹤0.01%	728
2017 Q3	$9K	Hold	160	–	–	﹤0.01%	731
2017 Q2	$10K	Hold	160	–	–	﹤0.01%	719
2017 Q1	$9K	Hold	160	–	–	﹤0.01%	702
2016 Q4	$10K	Buy	160 +80	+100%	+$5.21K	﹤0.01%	689
2016 Q3	$6K	Hold	80	–	–	﹤0.01%	746
2016 Q2	$4K	Buy	+80	New	+$4.82K	﹤0.01%	764

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Smithfield Trust's USNA Position: Q1 2018 in Review

Smithfield Trust sold out of Usana Health Sciences (USNA) in Q1 2018, closing a stake of 160 shares — an estimated $12K sold.

Smithfield Trust first reported a position in USNA in Q2 2016 and held it in 7 quarters. The position peaked at $12K in Q4 2017. 168 funds tracked by Wall St. Rank hold USNA as of Q1 2018.

Smithfield Trust reported no remaining Usana Health Sciences position as of Q1 2018 after selling out during the quarter.
Smithfield Trust sold 160 Usana Health Sciences shares in Q1 2018, an estimated $12K.
Smithfield Trust first reported a position in Usana Health Sciences in Q2 2016 and held it in 7 quarters.
Smithfield Trust's Usana Health Sciences position peaked at $12K in Q4 2017.
168 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2018.

Based on Smithfield Trust's 13F filing for Q1 2018, filed 10 May 2018.